Oncternal Therapeutics Reports Granting of Inducement

Oncternal Therapeutics Reports Granting of Inducement

News Highlights

SAN DIEGO, May 03, 2021 (News) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it has granted inducement awards to two new non-executive employees.

The awards were made on May 3, 2021 under Oncternal’s 2021 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Oncternal as an inducement to join the Company. The inducement awards consist of options to purchase 219,400 shares of Oncternal common stock. The options have a 10-year term and an exercise price equal to the closing price of Oncternal’s common stock on May 3, 2021. The options vest over a four-year period, with 25% of the options vesting on the first anniversary of each employee’s start date, and the rest vesting in equal monthly installments over three years thereafter. The awards were approved by Oncternal’s compensation committee, comprised entirely of independent directors, as required by Nasdaq Rule 5635(c)(4), and were granted as an inducement material to the new employees entering into employment with Oncternal in accordance with Nasdaq Rule 5635(c)(4).

About Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer generation or progression. The clinical pipeline includes cirmtuzumab, an investigational monoclonal antibody designed to inhibit the ROR1 pathway, a type I tyrosine kinase-like orphan receptor, that is being evaluated in a Phase 1/2 clinical trial in combination with ibrutinib for the treatment of patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) and in investigator-sponsored, Phase 1b clinical trial in combination with paclitaxel for the treatment of women with HER2-negative metastatic or locally advanced, unresectable breast cancer, as well as a Phase 2 clinical trial of cirmtuzumab in combination with venetoclax, a Bcl-2 inhibitor, in patients with relapsed/refractory CLL. We are also developing a chimeric antigen receptor T cell (CAR-T) therapy that targets ROR1, which is currently in preclinical development as a potential treatment for hematologic cancers and solid tumors. The clinical pipeline also includes TK216, an investigational targeted small-molecule inhibitor of the ETS family of oncoproteins, that is being evaluated in a Phase 1/2 clinical trial for patients with Ewing sarcoma alone and in combination with vincristine chemotherapy. More information is available at https://oncternal.com.

Oncternal Contacts:

Company ContactRichard Vincent 858-434-1113rvincent@oncternal.com

Investor ContactCorey Davis, Ph.D.            LifeSci Advisors                 212-915-2577                   cdavis@lifesciadvisors.com

Source: Oncternal Therapeutics, Inc.

 

  • Check the latest Health news updates and information.
  • Please share this news Oncternal Therapeutics Reports Granting of Inducement with your friends and family to support us your one share helps us a lot.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
The US economy is back.  Companies are not ready.

The US economy is back. Companies are not ready.

Here is how the disjointed recovery is playing out, and what each industry is doing about it. The checkered nature of this economic resurgence is a fresh ...
Reminder: today is the last chance to download Horizon Zero Dawn for free

Reminder: today is the last chance to download Horizon Zero Dawn for free

Horizon: Forbidden West will be released for PS5 and PS4 in 2021 As part of Play At Home 2021, PlayStation owners were previously able to download 2016’s ...
Alibaba swings to its first defeat since it went public

Alibaba swings to its first defeat since it went public

“We can see so many of our competitors are running huge losses and investing huge amounts . . . there is no reason for us not to be investing,” said chief ...
One Hand Clapping is a musical puzzle game that will be available on iOS and Android.

One Hand Clapping is a musical puzzle game that will be available on iOS and Android.

It’s being developed by Bad Dream Games, and is all about using your microphone to express yourself and beat the various puzzles the game throws at you. ...
FDA for healthcare facilities: OK for the ‘transition’ from reusing disposable respirators |  2021-05-14

FDA for healthcare facilities: OK for the ‘transition’ from reusing disposable respirators | 2021-05-14

Source NIOSH and CDC also have updated their online guidance document Strategies for Optimizing the Supply of N95 Respirators.   Use decontaminated ...
Who’s lighting all those damn candles in video games?

Who’s lighting all those damn candles in video games?

ESPECIALLY in Mortal Kombat, and I love me some MK, but unless if there’s a stage fatality where I can knock your ass out into a labyrinth of scented candle ...
Have we reached the ‘final frontier’ with payments in real time?

Have we reached the ‘final frontier’ with payments in real time?

Though it’s a seemingly crowded market space, the host of companies that are emerging function more as a complementary system of options for businesses rather ...
Huntsville discusses program to help police respond to mental health calls

Huntsville discusses program to help police respond to mental health calls

Thursday night, HPD laid out its plans for a co-response program with Wellstone. HPD currently has 75 CIT-certified officers. “Since 2019 we have been able to ...
Stevens Point responds to new mask orientation

Stevens Point responds to new mask orientation

Dr. Anthony Fauci, the director of the U.S. National Institute of Allergy and Infectious Diseases, said there’s nothing wrong with still wearing a mask, if ...
With ‘Game Builder Garage,’ Nintendo wants to show you how to make video games

With ‘Game Builder Garage,’ Nintendo wants to show you how to make video games

Game Builder Garage will be available for the Nintendo Switch starting next 11th of June. However, it is important to note that it will not be free. You will ...
Show next
Compsmag - Latest News from tech, business and health
Logo